Sunmax Biotechnology Co (ROCO:4728) Total Equity: NT$1,618 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4728 Sunmax Biotechnology Co Ltd ROCO:4728
91 GF Score
Price NT$381.00
GF Value NT$441.22
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sunmax Biotechnology Co Total Equity?

Sunmax Biotechnology Co ROCO:4728 +1.06% 91 Total Equity is NT$1,618 Mil as of Dec. 2025. GuruFocus rates ROCO:4728 with a GF Score™ of 91/100 and a GF Value™ of NT$441.22 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Sunmax Biotechnology Co's total equity for the quarter that ended in Dec. 2025 was NT$1,618 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Sunmax Biotechnology Co Total Equity Historical Data

* Premium members only.

The historical data trend for Sunmax Biotechnology Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunmax Biotechnology Co Total Equity Chart

Sunmax Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,023.58 1,325.28 1,426.05 1,512.84 1,617.76

Sunmax Biotechnology Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,512.84 1,108.88 1,244.44 1,444.43 1,617.76
ROCO:4728
91GF Score
Sunmax Biotechnology Co Ltd ROCO:4728
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunmax Biotechnology Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Sunmax Biotechnology Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2123.36-505.596
=1,618

Sunmax Biotechnology Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2123.36-505.596
=1,618

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$1,618 Mil mean?
Sunmax Biotechnology Co (ROCO:4728) has a Total Equity of NT$1,618 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Sunmax Biotechnology Co and its competitors.
Is Sunmax Biotechnology Co's Total Equity too high?
Sunmax Biotechnology Co's current Total Equity is NT$1,618 Mil. Overall, Sunmax Biotechnology Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunmax Biotechnology Co's Total Equity compare to VRTX and REGN?
Sunmax Biotechnology Co's Total Equity of NT$1,618 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Sunmax Biotechnology Co and its competitors. Sunmax Biotechnology Co's current Total Equity is NT$1,618 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunmax Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sunmax Biotechnology Co (ROCO:4728) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$441.22, compared to a current price of NT$381.00 — trading 13.6% below its estimated fair value. The current Total Equity is NT$1,618 Mil. Sunmax Biotechnology Co's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Sunmax Biotechnology Co (ROCO:4728), the current Total Equity is NT$1,618 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunmax Biotechnology Co (ROCO:4728) Overvalued in 2026?

Based on GuruFocus' analysis, Sunmax Biotechnology Co stock appears to be undervalued. The current stock price of NT$381.00 is trading 13.6% below its estimated GF Value™ of NT$441.22. GuruFocus considers Sunmax Biotechnology Co to be Modestly Undervalued.

Key valuation signals for ROCO:4728:

  • Total Equity: NT$1,618 Mil
  • GF Value™: NT$441.22 vs. price of NT$381.00 (13.6% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4728 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunmax Biotechnology Co Business Description

Address Huandong Road, New Urban District, 1st Floor, No. 10, Lane 31, Section 1, Tainan Science Industrial Park, Tainan, TWN
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.
91GF Score

Get the complete analysis for ROCO:4728

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$381.00
Price
NT$441.22
GF Value